Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LIPE | Q05469 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 3/20 | 0.41 |
| ▸ | MMP9 | P14780 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.40 |
| ▸ | GHSR | Q92847 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25968671 | 1.00 | ESR1 (0.43) | ESR1ESR2ALDH1A1LIPEKDM4E | |
| SCHEMBL31566053 | 0.95 | ESR1 (0.43) | ESR1ESR2ALDH1A1LIPEKDM4E | |
| SCHEMBL31565933 | 0.91 | ALDH1A1 (0.47) | ESR1ESR2ALDH1A1LIPEKDM4E | |
| SCHEMBL31566042 | 0.90 | ALDH1A1 (0.45) | ESR1ESR2ALDH1A1LIPEKDM4E | |
| SCHEMBL31565953 | 0.90 | ALDH1A1 (0.43) | ESR1ESR2ALDH1A1LIPEKDM4E | |
| SCHEMBL31566058 | 0.90 | ESR1 (0.45) | ESR1ESR2ALDH1A1LIPEMMP2 | |
| SCHEMBL31565853 | 0.88 | ESR1 (0.45) | ESR1ESR2LIPEKDM4EKMT2A | |
| SCHEMBL31565857 | 0.87 | LIPE (0.45) | ESR1ESR2ALDH1A1LIPEKDM4E | |
| SCHEMBL31566113 | 0.87 | ALDH1A1 (0.45) | ESR1ESR2ALDH1A1KDM4EKMT2A | |
| SCHEMBL31565962 | 0.87 | S1PR1 (0.50) | ESR1ESR2ALDH1A1LIPEKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129028-A1 | COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR | Opna Bio SA (CH) | 2025-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129028-A1 | COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR | YAP1, YES1, LATS1 | ESR1 998/4885ESR2 797/4885ALDH1A1 2760/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.